Author

MC Louie

Observed names: M Louie, M. Louie

Institutions: Translational Genomics Research Institute, Mayo Clinic, University of Leicester, University of California, San Francisco, University of Alabama at Birmingham, Natera (United States), The Christie NHS Foundation Trust, Imperial College London, University of Pennsylvania

Observed institutions: Translational Genomics Research Institute, Mayo Clinic, University of Leicester, University of California, San Francisco, University of Alabama at Birmingham, Natera (United States), The Christie NHS Foundation Trust, Imperial College London, University of Pennsylvania

OpenAlex ID: A5065711396

Presence of circulating tumour DNA in surgically resected renal cell carcinoma is associated with advanced disease and poor patient prognosis

2019 · A. Correa, D.C. Connolly, et al. · Annals of Oncology · 11

Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL

2019 · MJM Magbanua, L Brown-Swigart, et al. · Cancer Research · 9

Abstract P4-01-02: Early detection of residual breast cancer through a robust, scalable and personalized analysis of circulating tumour DNA (ctDNA) antedates overt metastatic recurrence

2019 · RC Coombes, A Armstrong, et al. · Cancer Research · 8

Works count: 3

Citation count: 28

H-index: 3

I10-index: 1